The Australia Oxygen Concentrator Market reached a market size of USD 98.00 Million in 2024, with expectations to grow to USD 189.21 Million by 2033. The market is set to expand over the forecast period of 2025-2033 at a growth rate of 6.80%. Growth is driven by the increasing prevalence of respiratory diseases, technological advances in oxygen therapy, and rising awareness of oxygen therapy benefits in home care settings. Government initiatives and a growing geriatric population also boost market demand.

How AI is Reshaping the Future of Australia Oxygen Concentrator Market

• AI-driven smart monitoring features enable real-time health data collection and remote alerts, enhancing patient care and device management.

• Integration of AI with portable oxygen concentrators increases device efficiency by optimizing oxygen flow based on patient needs, improving therapy outcomes.

• AI-powered predictive maintenance reduces downtime through early detection of device faults, ensuring uninterrupted oxygen supply.

• Government healthcare initiatives support AI-enabled home-care oxygen solutions, increasing accessibility for remote and Indigenous populations.

• AI facilitates personalized oxygen therapy by analyzing individual respiratory patterns, improving patient adherence and satisfaction.

• AI advances aid manufacturers in developing compact, energy-efficient concentrators with noise reduction, aligning with consumer demand for user-friendly devices.

Grab a sample PDF of this report: https://www.imarcgroup.com/australia-oxygen-concentrator-market/requestsample

Market Growth Factors

The increasing prevalence of respiratory diseases is a major growth driver for the Australia oxygen concentrator market. Chronic respiratory ailments like Chronic Obstructive Pulmonary Disease (COPD) and asthma have notably risen, with asthma burden increasing by 8.5% since 2003 according to AIHW's 2024 Burden of Disease Study. These diseases require long-term oxygen therapy to manage symptoms and reduce hospitalizations. Patients are increasingly choosing oxygen concentrators, both portable and stationary, to improve oxygen levels and quality of life at home, fostering significant market demand.

Australia’s aging population substantially contributes to market growth. Projections indicate nearly 25% of the population will be aged 65 and over by 2064–65, driving higher prevalence of age-related respiratory conditions such as COPD and emphysema that necessitate oxygen therapy. The government’s reform efforts to improve aged care and support Indigenous communities, combined with rising availability of affordable concentrators, encourage elderly patients to opt for home-based oxygen therapy, reducing hospital visits and enhancing lifestyle quality.

Environmental factors and regional vulnerabilities also propel market expansion. Frequent natural occurrences like bushfires, dust storms, and high pollen seasons across regions such as New South Wales, Victoria, and Western Australia degrade air quality and exacerbate respiratory health issues. This has heightened awareness of at-home respiratory therapies. The isolation of many communities in Australia, distant from hospitals, generates demand for portable oxygen concentrators capable of delivering stable therapy during climate-related respiratory distress, thereby strengthening market traction.